NCT00928135View on ClinicalTrials.gov

Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

January 22, 2013

Primary Completion Date

April 9, 2018

Study Completion Date

April 9, 2018

Conditions
Cystic Fibrosis
Interventions
DRUG

Xylitol

15% xylitol solution for aerosol; Dosage: 5 ml twice a day (BID)

DRUG

Hypertonic saline

7% hypertonic saline solution for aerosol; Dosage: 5 ml twice a day (BID)

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
lead

Joseph Zabner

OTHER

NCT00928135 - Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects | Biotech Hunter | Biotech Hunter